Cabalin CR Sustained Release Tablet 150 mg (Pregabalin)

Adult dosage

This medication should be taken once daily after the evening meal. It should be swallowed whole and not divided, crushed, or chewed. A starting dose of 150 mg once daily may be given. Based on individual patient response and tolerance, the dose may be increased to a maximum of 600 mg per day at weekly intervals. If discontinuing treatment, it should be done gradually with at least a one-week interval.

This medication may increase the risk of suicidal thoughts or behaviors; therefore, if any symptoms of depression or changes in mood occur during treatment, you must inform your healthcare provider immediately. Patients allergic to pregabalin or any components of this medication should not take it. Diabetic patients may experience weight gain after taking this medication, which may require adjustments in their blood sugar control medications. If allergic reactions, such as angioedema, occur, discontinue use immediately and consult a doctor. Elderly patients may experience increased dizziness or drowsiness, so caution should be exercised during the initial treatment period to avoid falls or accidents. Transient blurred vision or changes in vision may occur; if these symptoms appear, you should consult a doctor. Abrupt discontinuation of this medication may lead to withdrawal symptoms, such as insomnia, headaches, nausea, and anxiety; therefore, it should be gradually reduced according to the physician's instructions. Due to the risk of drug abuse, patients with a history of substance abuse or mental disorders should be particularly cautious. Patients with impaired kidney function should have their dosage adjusted, and patients with severe heart conditions should also take this medication with caution. Taking this medication with opioid analgesics may increase the risk of central nervous system depression; caution is advised. Patients with compromised respiratory function or the elderly may have an increased risk of severe respiratory depression and may require dosage adjustments during treatment. It is recommended not to take this medication in early pregnancy due to the risk of fetal malformations, and women of childbearing age should use effective contraception. Breastfeeding women should consult their doctors regarding whether to discontinue breastfeeding or the medication, as this medication may pass into breast milk and affect the infant. It is advisable to avoid hazardous activities such as driving or operating machinery until dizziness or drowsiness has resolved after taking this medication. In the event of an overdose, symptoms such as confusion, drowsiness, depression, and seizures may arise, and immediate medical treatment should be sought.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain of oral/eye mucosa, shortness of breath or difficulty breathing, asthma exacerbation, respiratory problems accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme fatigue, sudden and severe headaches, thunderclap headache, seizures, altered consciousness, visual disturbances, paralysis, urinary issues.

Mild side effects

• Dizziness
• drowsiness
• headache
• lethargy
• somnolence
• constipation
• dyspepsia
• nausea
• dry mouth
• vomiting

This medication must be stored in a tightly closed container to avoid exposure to air or moisture. It is important to maintain storage temperatures between 1°C and 30°C to safely preserve the medication's effectiveness.

Appearance

White to light yellow, rectangular film-coated sustained-release tablet.

Package unit

30 tablets (6 tablets/PTP x 5)